Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

BioLineRx - 14 Year Stock Price History | BLRX

Historical daily share price chart and data for BioLineRx since 2011 adjusted for splits and dividends. The latest closing stock price for BioLineRx as of July 03, 2025 is 4.49.
  • The all-time high BioLineRx stock closing price was 3354.00 on July 25, 2011.
  • The BioLineRx 52-week high stock price is 35.60, which is 692.9% above the current share price.
  • The BioLineRx 52-week low stock price is 2.30, which is 48.8% below the current share price.
  • The average BioLineRx stock price for the last 52 weeks is 12.45.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
BioLineRx Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 3.8747 10.2240 10.9520 2.4300 4.4900 -47.55%
2024 29.5721 61.2000 62.2000 7.8080 8.5600 -86.37%
2023 52.7734 26.0000 98.0000 22.5120 62.8000 166.10%
2022 52.9454 83.2000 87.2000 22.6480 23.6000 -71.08%
2021 115.1000 98.0000 195.2000 79.2000 81.6000 -19.05%
2020 77.6543 93.6000 144.8000 44.4000 100.8000 12.00%
2019 187.9434 300.0000 440.4600 78.8000 90.0000 -65.70%
2018 543.2278 660.0000 870.0000 260.9400 262.3800 -59.88%
2017 609.2000 562.7400 783.0000 487.8000 654.0000 18.48%
2016 584.6662 780.0000 780.0000 450.0000 552.0000 -29.23%
2015 1089.1427 1026.0000 1704.0000 738.0010 780.0000 -19.75%
2014 1204.3703 1740.0000 1842.0000 738.0010 972.0000 -42.35%
2013 1465.2072 1590.0000 2850.0000 948.0010 1686.0000 11.07%
2012 1697.3059 1893.6000 3330.0000 1338.0000 1518.0000 -20.19%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.019B $0.029B
Bioline RX Ltd. is a biopharmaceutical development company. BioLineRx is dedicated to building a portfolio of products for unmet medical needs or with advantages over currently available therapies. The Company's portfolio consists of clinical stage candidates including BL-1020 for schizophrenia , BL-1040, for treatment of patients following a myocardial infarction, BL-5010 for non-surgical removal of skin lesions, BL-1021 for neuropathic pain and BL-7040 for treating Inflammatory Bowel Disease. In addition, BioLineRx has many products in various pre-clinical development stages for a variety of indications, including central nervous system diseases, oncology, infectious diseases, cardiovascular and autoimmune diseases.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $80.499B 30.20
Zoetis (ZTS) United States $70.868B 26.44
Takeda Pharmaceutical (TAK) Japan $48.811B 9.71
Daiichi Sankyo, - (DSNKY) Japan $42.149B 21.60
BeOne Medicines - (ONC) Cayman Islands $26.906B 0.00
Sandoz Group AG (SDZNY) Switzerland $23.786B 0.00
Summit Therapeutics (SMMT) United States $18.232B 0.00
Merck (MKKGY) Germany $16.850B 12.35
Shionogi (SGIOY) Japan $14.717B 14.74
United Therapeutics (UTHR) United States $13.283B 11.75
Neurocrine Biosciences (NBIX) United States $12.777B 43.77
Orion OYJ (ORINY) Finland $10.495B 28.38
IPSEN (IPSEY) France $10.061B 0.00
Corcept Therapeutics (CORT) United States $7.664B 62.30
Stevanato Group S.p.A (STVN) Italy $7.447B 45.54
Ionis Pharmaceuticals (IONS) United States $6.844B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.636B 0.00
Grifols, S.A (GRFS) Spain $6.243B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.382B 13.33
Soleno Therapeutics (SLNO) United States $4.367B 0.00
Hypermarcas (HYPMY) Brazil $3.183B 20.94
Crinetics Pharmaceuticals (CRNX) United States $2.790B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.639B 14.27
Catalyst Pharmaceuticals (CPRX) United States $2.618B 9.17
NewAmsterdam Pharma (NAMS) Netherlands $2.229B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.879B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.871B 0.00
ARS Pharmaceuticals (SPRY) United States $1.622B 0.00
Endo (NDOI) United States $1.603B 0.00
Ocular Therapeutix (OCUL) United States $1.532B 0.00
Evotec AG (EVO) Germany $1.491B 0.00
Guardian Pharmacy Services (GRDN) United States $1.320B 0.00
Harrow (HROW) United States $1.165B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.025B 20.51
Ardelyx (ARDX) United States $1.022B 0.00
Enliven Therapeutics (ELVN) United States $1.017B 0.00
Verve Therapeutics (VERV) United States $1.006B 0.00
Dyne Therapeutics (DYN) United States $0.996B 0.00
Collegium Pharmaceutical (COLL) United States $0.975B 5.26
Akebia Therapeutics (AKBA) United States $0.951B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.864B 0.00
Cronos Group (CRON) Canada $0.787B 0.00
Xeris Biopharma Holdings (XERS) United States $0.743B 0.00
Elite Pharmaceuticals (ELTP) United States $0.640B 0.00
Relay Therapeutics (RLAY) United States $0.622B 0.00
USANA Health Sciences (USNA) United States $0.610B 13.27
Xencor (XNCR) United States $0.599B 0.00
KalVista Pharmaceuticals (KALV) United States $0.596B 0.00
Bioventus (BVS) United States $0.577B 14.62
Amylyx Pharmaceuticals (AMLX) United States $0.562B 0.00
Theravance Biopharma (TBPH) United States $0.558B 0.00
Organogenesis (ORGO) United States $0.539B 0.00
Zevra Therapeutics (ZVRA) United States $0.533B 0.00
Siga Technologies (SIGA) United States $0.478B 9.99
Oruka Therapeutics (ORKA) United States $0.472B 0.00
Tourmaline Bio (TRML) United States $0.422B 0.00
AleAnna (ANNA) United States $0.420B 0.00
Altimmune (ALT) United States $0.386B 0.00
Savara (SVRA) United States $0.379B 0.00
Aquestive Therapeutics (AQST) United States $0.370B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.338B 9.14
Heron Therapeutics (HRTX) United States $0.336B 0.00
Nektar Therapeutics (NKTR) United States $0.307B 0.00
Nature's Sunshine Products (NATR) United States $0.288B 26.42
Tonix Pharmaceuticals Holding (TNXP) United States $0.261B 0.00
Aldeyra Therapeutics (ALDX) United States $0.258B 0.00
OmniAb (OABI) United States $0.236B 0.00
Liminatus Pharma (LIMN) United States $0.235B 0.00
Esperion Therapeutics (ESPR) United States $0.232B 0.00
Nanobiotix S.A (NBTX) France $0.230B 0.00
China SXT Pharmaceuticals (SXTC) China $0.218B 0.00
MediWound (MDWD) Israel $0.209B 0.00
Larimar Therapeutics (LRMR) United States $0.205B 0.00
4D Molecular Therapeutics (FDMT) United States $0.196B 0.00
ProKidney (PROK) United States $0.187B 0.00
Profound Medical (PROF) Canada $0.180B 0.00
Journey Medical (DERM) United States $0.165B 0.00
Innate Pharma SA (IPHYF) France $0.163B 0.00
Aclaris Therapeutics (ACRS) United States $0.156B 0.00
Lexeo Therapeutics (LXEO) United States $0.148B 0.00
Lyell Immunopharma (LYEL) United States $0.143B 0.00
Avita Medical (RCEL) United States $0.143B 0.00
Inhibikase Therapeutics (IKT) United States $0.141B 0.00
Galectin Therapeutics (GALT) United States $0.138B 0.00
Cardiol Therapeutics (CRDL) Canada $0.127B 0.00
Korro Bio (KRRO) United States $0.125B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.124B 0.00
Protara Therapeutics (TARA) United States $0.112B 0.00
Nutriband (NTRB) United States $0.111B 0.00
Champions Oncology (CSBR) United States $0.106B 17.45
VAXART, INC (VXRT) United States $0.097B 0.00
Cassava Sciences (SAVA) United States $0.097B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.094B 0.00
Arch Biopartners (ACHFF) Canada $0.086B 0.00
Fractyl Health (GUTS) United States $0.081B 0.00
ESSA Pharma (EPIX) Canada $0.077B 0.00
Dominari Holdings (DOMH) United States $0.077B 0.00
Achieve Life Sciences (ACHV) Canada $0.076B 0.00
Vivani Medical (VANI) United States $0.075B 0.00
Inotiv (NOTV) United States $0.072B 0.00
Surrozen (SRZN) United States $0.072B 0.00
Pyxis Oncology (PYXS) United States $0.068B 0.00
Rafael Holdings (RFL) United States $0.066B 0.00
Wellgistics Health (WGRX) United States $0.065B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.065B 0.00
Assertio Holdings (ASRT) United States $0.063B 0.00
Metagenomi (MGX) United States $0.062B 0.00
PMV Pharmaceuticals (PMVP) United States $0.062B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
NRx Pharmaceuticals (NRXP) United States $0.058B 0.00
Unicycive Therapeutics (UNCY) United States $0.058B 0.00
Context Therapeutics (CNTX) United States $0.057B 0.00
Jupiter Neurosciences (JUNS) United States $0.055B 0.00
Avalo Therapeutics (AVTX) United States $0.054B 0.00
Gain Therapeutics (GANX) United States $0.051B 0.00
Century Therapeutics (IPSC) United States $0.048B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.047B 35.00
ElectroCore (ECOR) United States $0.045B 0.00
Prelude Therapeutics (PRLD) United States $0.045B 0.00
Mural Oncology (MURA) Ireland $0.045B 0.00
Acrivon Therapeutics (ACRV) United States $0.040B 0.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
Karyopharm Therapeutics (KPTI) United States $0.038B 0.00
Klotho Neurosciences (KLTO) United States $0.037B 0.00
PolyPid (PYPD) Israel $0.036B 0.00
Telomir Pharmaceuticals (TELO) United States $0.034B 0.00
SCYNEXIS (SCYX) United States $0.029B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
Tempest Therapeutics (TPST) United States $0.026B 0.00
Vivos Therapeutics (VVOS) United States $0.026B 0.00
Citius Pharmaceuticals (CTXR) United States $0.024B 0.00
FibroGen (FGEN) United States $0.023B 0.00
VYNE Therapeutics (VYNE) United States $0.022B 0.00
Relmada Therapeutics (RLMD) United States $0.021B 0.00
DURECT (DRRX) United States $0.021B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
Scienture Holdings (SCNX) United States $0.019B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.018B 0.00
BioVie (BIVI) United States $0.018B 0.00
Mannatech (MTEX) United States $0.017B 0.00
ProPhase Labs (PRPH) United States $0.017B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.017B 0.00
Carisma Therapeutics (CARM) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
CASI Pharmaceuticals (CASI) China $0.016B 0.00
Plus Therapeutics (PSTV) United States $0.015B 0.00
Ernexa Therapeutics (ERNA) United States $0.015B 0.00
Ainos (AIMD) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.012B 2.01
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Talphera (TLPH) United States $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Alaunos Therapeutics (TCRT) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Qualigen Therapeutics (QLGN) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.005B 0.00
SHINECO (SISI) China $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Heatwurx (PCSA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 9.01
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00
SciSparc (SPRC) Israel $0.000B 0.00